A Statement from Advent International on the Passing of Thomas H. Lee

The entire Advent team is saddened to hear about the tragic loss of Thomas H. Lee. Tom was a friend, a visionary, a business partner and one of the private equity industry’s earliest pioneers. He was also an incredible philanthropic leader in the Boston and New York communities as well as many other fortunate areas and organizations he touched. Our thoughts and prayers are with Ann and the entire Lee family along with all of Tom’s countless friends and colleagues around the world.

– David Mussafer, on behalf of all of Tom’s friends at Advent International

Advent International invests in LBS Group, a leading pest control operation and hygiene solutions provider in Greater China

Shanghai, 23 February 2023 – Advent International (“Advent”), one of the world’s largest and most experienced private equity investors, today announced that it has invested in LBS Group (“LBS”), a leading pest control operation (PCO) and hygiene solutions provider in Greater China.

LBS Group offers a wide range of pest control and hygiene management products and services in Asia. It has grown its offering since it was established in 1998 to include integrated pest control management, hygiene services, Sani-Mist germicidal treatment and grease remedial services for global F&B customers, retailers, offices, hotels, and industrial and household customers. The company is a major player in the PCO industry and operates in more than 30 cities across Greater China and southeast Asia.

The PCO market in China is expected to see rapid growth at a mid-teen CAGR over the next five years thanks to increasingly stringent hygiene standards and pest control requirements as well as improving food safety regulations. Advent’s investment in LBS Group will support the company’s continuing growth initiatives and its leading position in China’s PCO industry.

Irene Liu, Principal of Advent, commented, “Riding on China’s steadily increasing urbanization rate and improved hygiene standards, we believe the PCO sector has strong growth prospects. We are impressed by LBS’ superior service quality and very pleased to partner with its experienced and highly motivated team. We plan to contribute our global resources and relevant industry expertise to support the business.”

Franco Lam, Chairman of LBS Group, said, “I am excited to work with Advent during our next stage of growth in Greater China. I believe we will be great partners and LBS Group will continue to deliver excellent customer services.”

Andrew Li, Managing Director, Head of Greater China of Advent, said, “This deal reflects Advent’s continued commitment to invest in the Greater China region and our confidence in building successful businesses with the support of our global network. LBS has a strong track record in providing pest control and hygiene solutions and quality services to customers. We look forward to helping it grow and expand its footprint in the region.”

Advent has made multiple investments across Greater China, including Wagas Group, a major lifestyle F&B group in China; AI Dream, China’s leading branded sleep solution provider and the largest player in the country’s premium mattress market; BioDuro, a global life sciences contract research and development organization with major operations in Shanghai, Beijing and San Diego; and GS capsule, the largest domestic capsule provider in China.

About LBS Group

Founded in 1998, LBS Group is a pest control and hygiene solutions company with complementary services such as digital IoT pest monitoring, air purification and desludging services. As Greater China’s leading pest control company, LBS meets the needs of a wide range of customers in Greater China and the broader region and is the go-to vendor for many of its business partners in Food Services, Retail, Hospitality, Manufacturing and other end markets. Central to LBS’ culture and philosophy is the importance of caring about people. The concept of “planting the seed and the fruit will follow” is a core value embraced by every LBS employee. Respect, collaboration, helping others to succeed and community service before self-advancement has empowered the LBS team to strive for sustainable growth and build a bright future together.

About Advent International

Founded in 1984, Advent International is one of the largest and most experienced global private equity investors. The firm has invested in over 405 private equity investments across 42 countries, and as of September 30, 2022, had $89 billion in assets under management. With 15 offices in 12 countries, Advent has established a globally integrated team of over 290 private equity investment professionals across North America, Europe, Latin America and Asia. The firm focuses on investments in five core sectors, including business and financial services; health care; industrial; retail, consumer and leisure; and technology. For over 35 years, Advent has been dedicated to international investing and remains committed to partnering with management teams to deliver sustained revenue and earnings growth for its portfolio companies.

For more information, please visit
www.adventinternational.com and follow Advent on LinkedIn.

Media contacts

FTI Consulting
Izzie Shen (Shanghai)
Tel: +86 21 2315 1068
izzie.shen@fticonsulting.com

Jenna Qian (Hong Kong)
Tel: +852 9839 0019
jena.qian@fticonsulting.com

 

Boasso Global and Quala to Merge, Creating a Leading Infrastructure Service Provider for Liquid Bulk Logistics Industry

Tampa, FL – February 9, 2023 – Boasso Global, Inc. (“Boasso”) and Q Super Holdings, Inc. (“Quala”) today announced the signing of a definitive agreement under which the companies will merge their complementary businesses to create one of the leading infrastructure services solution providers for the liquid bulk logistics industry. The transaction is supported by a new investment from Boasso’s majority shareholder, KKR, through its KKR Global Infrastructure Investors IV fund. Under the terms of the agreement, KKR will inject further growth capital into Boasso to facilitate the merger with Quala via a purchase of shares from Advent International (“Advent”) and invest in the strategic combination of the two businesses.

Quala is one of the North American leaders in liquid bulk container cleaning and maintenance services, including tank trailer, ISO tank container, railcar and IBC cleaning, and Boasso is a leading provider of mission-critical infrastructure services for the ISO tank container industry in North America and Europe. Upon completion of the merger, the companies will combine their complementary geographical footprints and service offerings to deliver enhanced solutions for customers across the liquid bulk logistics industry in North America and Europe.

“Boasso and Quala are premier infrastructure service providers to the global liquid bulk logistics ecosystem with trusted reputations and highly complementary networks and service offerings,” said Dash Lane, Partner at KKR. “This transaction is about growth and empowering the two great teams led by Joe Troy and Scott Harrison to come together and make long-term investments in quality, safety and superior solutions for customers.”

Joe Troy, Chief Executive Officer of Boasso, said: “We are focused on meeting the needs of our global customers and the combination of Boasso and Quala makes perfect strategic sense. This transaction will enhance our ability to deliver safe, compliant and best-in-class services to our ISO tank container customers and meaningfully expand our access to more locations across North America to better serve their needs. This is a rare opportunity to put together two Tampa-based, complementary businesses and I am excited to work with Scott and his talented team to unite the best of our organizations with a focus on enhanced efficiency and growing our range of premium solutions for the liquid bulk logistics industry.”

Scott Harrison, Chief Executive Officer of Quala, said: “Our organizations not only have a strong commercial relationship, but also shared cultures of delivering excellence, innovation and safety for our customers. This combination with Boasso and new investment from KKR will allow us to advance our position as a leading provider of container cleaning and maintenance services while continuing to seamlessly meet our customers’ needs. Together Quala and Boasso will benefit from greater connectivity to our customers, an expanded global footprint and new opportunities for our team members as part of a larger combined organization.”

Since Advent’s investment in Quala in 2016, the company cemented its position as the largest independent tank wash, inspection, maintenance and repair solutions provider in North America. Through both organic and inorganic initiatives, Quala has grown significantly, expanding across services and markets to further enhance its customer offering. Under Advent’s ownership, the company invested heavily in building out the platform – including critical investments in safety, talent and technology. Quala’s accomplishments include developing a proprietary technology suite, OnTrax, to make Quala’s services more seamless for customers. Advent’s investment enabled Quala to scale its footprint from 60 locations and 500 employees to 119 locations and over 1,800 employees today and the company has achieved substantial profitable growth across key metrics while building and growing its employee stock ownership program.

Stephen Hoffmeister, Managing Director at Advent International, said: “We have been proud to partner with Scott and Quala’s senior leadership team as they have transformed their company into an industry leader. The Quala management team has delivered compelling performance by driving an employee first culture, technological innovation and customer excellence. Quala is a well invested platform strategically positioned to continue its success and make important investments for its people.”

The transaction, which is subject to the receipt of required regulatory approvals and satisfying other customary closing conditions, is expected to close in the first half of 2023. Boasso and KKR were advised by Simpson Thacher & Bartlett, LLP as legal counsel and by Citi as financial advisor. Quala and Advent were advised by Weil Gotshal & Manges, LLP as legal counsel and by Credit Suisse as lead financial advisor and Bank of America as financial advisor.

About Boasso Global

Headquartered in Tampa, Florida, Boasso Global is a leading international provider of depot and transportation services to a fast-growing, global ISO tank container industry. Boasso offers a multitude of mission-critical services through a network of 34 international depots, including 17 in North America, 8 in the United Kingdom, and 9 in Continental Europe. Boasso is a Responsible Care certified member within the American Chemistry Council. For more information, visit www.boassoglobal.com.

About Quala

Headquartered in Tampa, Florida, Quala is the largest independent provider of comprehensive cleaning, test, and repair services for Tank Trailers, ISO Containers, IBCs, and Railcars. Founded in 1986, the company began independent operations in 2009 and today has 119 locations. For more information about Quala, visit our website at www.quala.us.com.

About KKR

KKR is a leading global investment firm that offers alternative asset management as well as capital markets and insurance solutions. KKR aims to generate attractive investment returns by following a patient and disciplined investment approach, employing world-class people and supporting growth in its portfolio companies and communities. KKR sponsors investment funds that invest in private equity, credit and real assets and has strategic partners that manage hedge funds. KKR’s insurance subsidiaries offer retirement, life and reinsurance products under the management of Global Atlantic Financial Group. References to KKR’s investments may include the activities of its sponsored funds and insurance subsidiaries. For additional information about KKR & Co. Inc. (NYSE: KKR), please visit KKR’s website at www.kkr.com and on Twitter @KKR_Co.

About Advent International

About Advent International
Founded in 1984, Advent International is one of the largest and most experienced global private equity investors. The firm has invested in over 405 private equity investments across 42 countries, and as of September 30, 2022, had €91 billion in assets under management. With 15 offices in 12 countries, Advent has established a globally integrated team of over 290 private equity investment professionals across North America, Europe, Latin America and Asia. The firm focuses on investments in five core sectors, including business and financial services; health care; industrial; retail, consumer and leisure; and technology. For over 35 years, Advent has been dedicated to international investing and remains committed to partnering with management teams to deliver sustained revenue and earnings growth for its portfolio companies.

For more information, visit
Website: www.adventinternational.com
LinkedIn: www.linkedin.com/company/advent-international

Media contacts

For Boasso:
Kyle Parks, B2 Communications
727-895-5030
kyle@b2communications.com

For Quala:
Paul Hofley
248-219-0012
Phofley@quala.us.com

For KKR:
Miles Radcliffe-Trenner
212-750-8300
media@kkr.com

For Advent:
Zachary Tramonti / Anna Epstein
FGS Global
212-687-8080
adventinternational-us@fgsglobal.com

Kerry to sell its Sweet Ingredients Portfolio to Advent International’s portfolio company, IRCA

Kerry Group plc today announces that it has entered into exclusive negotiations to sell the trade and assets of its Sweet Ingredients Portfolio to IRCA (“the Potential Sale”), an international leader in chocolate, creams, and other high-quality semi-finished food ingredients, for a consideration of 500m1. The Potential Sale is subject to relevant regulatory approvals and routine closing adjustments. Employee consultation and information processes have commenced in relevant jurisdictions.

The Sweet Ingredients Portfolio is a leading manufacturer of sweet and cereal products with a broad range of technological capabilities, primarily serving the end markets of bakery, cereal, confectionery, dairy and ice cream in Europe and the US. Its operational footprint covers four manufacturing facilities in the US (in Illinois, Kansas, Missouri, and California), and six facilities across the UK, the Netherlands, Germany and France. The portfolio incorporates a range of products spanning sweet particulates, chocolate confections, baked inclusions, variegates and fruit purées. The expected attributable financial results for the year ended 31 December 2022 include revenues of €405m and EBITDA of €41m.

Edmond Scanlon, CEO of Kerry Group, commented: “We are pleased to have entered exclusive negotiations with IRCA, who have a strong track record of developing their business within the category. This transaction would represent another strategic development in Kerry’s evolution, as we continue to look to enhance and refine our Taste & Nutrition portfolio, aligned to the areas where we can create the most value.”

Massimo Garavaglia, CEO of IRCA, added: “We are delighted to partner with Kerry on this transaction and look forward to its successful conclusion. The Sweet Ingredients Portfolio is a high-quality business with a differentiated set of technologies, and we are excited to welcome their talented team who, we believe, share our passion and drive to deliver the best for their customers and consumers. This acquisition would represent a strong fit with our portfolio, with its highly complementary product and technological capabilities, and help us to become a truly global player. We look forward to helping the Sweet Ingredients Portfolio realise its full potential as part of the IRCA family.”

Francesco Casiraghi, Managing Director at Advent International, commented: “We are delighted to welcome this best-in-class sweet ingredients business to the IRCA family, which would represent a major step in our goal of creating a genuine global leader in semi-finished food ingredients. There are so many exciting long-term opportunities for this combination, and we look forward to supporting the management team in this next phase of growth for the business.”

The combination of IRCA and Kerry’s Sweet Ingredients Portfolio is expected to create a global leader in semi-finished food ingredients with around €1 billion in revenues, a truly international footprint and a significant presence in the US. It would further strengthen IRCA’s leadership positioning and expand its broad assortment of high value-added ingredients.

This would represent IRCA’s third acquisition since it was acquired by Advent International (“Advent”), one of the largest and most experienced global private equity investors, in July 2022. This follows the recent acquisitions of Anastasi Group, a leading Italian pistachio ingredients company, and of Cesarin SpA, a leading artisanal fruit-based ingredients company.

The Potential Sale is expected to close in the first half of 2023 following the employee consultation and information processes and receipt of regulatory approvals. On receipt, the proceeds from the Potential Sale are expected to be used by Kerry for general corporate purposes and the continued strategic development of the Taste & Nutrition business.

¹The consideration of €500m comprises an initial cash consideration of €375m (subject to routine closing adjustments) plus a €125m interest bearing vendor loan note.

About Kerry

Kerry is a world leading provider of taste and nutrition solutions for the food, beverage and pharmaceutical markets. We innovate with our customers to create great tasting products, with improved nutrition and functionality, while ensuring better impact for the planet. Our leading consumer insights, RD&A team of 1,100+ food scientists and extensive global footprint enable us to solve our customers’ complex challenges with differentiated solutions. At Kerry, we are driven to be our customers’ most valued partner, creating a world of sustainable nutrition. For more information, visit www.kerry.com.

About IRCA

IRCA is an international leader in chocolate, creams, and high-quality semi-finished food ingredients that for over 100 years has been supplying the professional channels across the world. The Group distributes its products across more than 100 countries and runs 13 production facilities in Italy, United States, Belgium, and Vietnam. Over 1,000 employees contribute every year to launching innovative products tailored to the latest industry trends, supplying a wide range of unique solutions to customers globally.

About Advent International

Founded in 1984, Advent International is one of the largest and most experienced global private equity investors. The firm has invested in over 400 private equity investments across 41 countries, and as of September 30, 2022, had €90 billion in assets under management. With 15 offices in 12 countries, Advent has established a globally integrated team of over 285 private equity investment professionals across North America, Europe, Latin America and Asia. The firm focuses on investments in five core sectors, including business and financial services; health care; industrial; retail, consumer and leisure; and technology. For over 35 years, Advent has been dedicated to international investing and remains committed to partnering with management teams to deliver sustained revenue and earnings growth for its portfolio companies.

For more information, visit:
Website: www.adventinternational.com
LinkedIn: www.linkedin.com/company/advent-international

Media contacts

KERRY

Investor Relations
Marguerite Larkin, Chief Financial Officer
+353 66 7182292 | investorrelations@kerry.ie

William Lynch, Head of Investor Relations
+353 66 7182292 | investorrelations@kerry.ie

Media
Catherine Keogh, Chief Corporate Affairs & Brand Officer
+353 45 930188 | corpaffairs@kerry.com

Website
www.kerry.com

IRCA

Media
Roberto Patriarca
+39 335 65 09568 | roberto.patriarca@community.it

Website
www.irca.eu/en

Advent International announces its annual promotions

Advent International (“Advent”), one of the largest and most experienced global private equity investors, is pleased to announce staff promotions across the global investment and corporate teams.

The promotions represent a wide range of talent and geographies from across the business, with:

  • Promotions by region: 30 North America, 23 Europe, 7 Latin America, 6 Asia
  • 29 female promotions

Four outstanding individuals are promoted to senior management levels of the firm and we offer our warmest congratulations:

  • Tricia Glynn, Boston, Managing Partner
  • Shonnel Malani, London, Managing Partner
  • David Chen, Shanghai, Managing Director
  • Rafael Patury, São Paulo, Managing Director

“Congratulations to all of our colleagues whose hard work, talent and dedication has been recognized in this round of promotions,” said David Mussafer, Managing Partner and Co-Chair of Advent’s Executive Committee. “Each of these individuals have made a significant contribution to Advent’s success, and I look forward to working with them in their new roles.”

“Our people are not only fundamental to the firm’s success, they are also what makes Advent a truly special place to work,” said James Brocklebank, Managing Partner and Co-Chair of Advent’s Executive Committee. “Recognizing and rewarding talent is central to the culture that Advent has built, and I congratulate each of this incredibly talented group on their promotions.”

Advent International

Founded in 1984, Advent International is one of the largest and most experienced global private equity investors. The firm has invested in over 400 private equity investments across 41 countries, and as of September 30, 2022, had $89 billion in assets under management. With 14 offices in 12 countries, Advent has established a globally integrated team of over 285 private equity investment professionals across North America, Europe, Latin America and Asia. The firm focuses on investments in five core sectors, including business and financial services; health care; industrial; retail, consumer and leisure; and technology.

For more information, please visit www.adventinternational.com and follow Advent on LinkedIn.

Advent International to acquire a significant stake in Suven Pharmaceuticals from the Jasti family

Advent intends to explore merger of Suven Pharma and Cohance Lifesciences to create one of the leading CDMO + API powerhouse subject to board and regulatory approvals

Mumbai, India, December 26, 2022: Advent International (“Advent”), one of the largest and most experienced global private equity investors, has entered into a definitive agreement to
acquire significant stake in Suven Pharmaceuticals (“Suven Pharma” or “Suven”) from the Jasti family, subject to regulatory approvals and conditions. Post the completion of this landmark acquisition, Advent intends to explore the merger of its portfolio company, Cohance
Lifesciences (“Cohance”) with Suven, to build a leading end-to-end CDMO and merchant API player servicing the pharma and specialty chemical markets. The merger will be evaluated by the board taking into consideration the strategic rationale and accretiveness to Suven’s public shareholders and will be subject to regulatory approvals and other customary approvals.

As part of the transaction, Advent will also be making an open offer to acquire additional 26% of the outstanding equity shares of the company from the public shareholders.

“We are delighted to bring Advent into Suven Pharma as a strategic investor. We have built a business with industry leading growth & margins. We have cultivated excellent relationships with multiple global innovator companies backed by deep R&D capabilities and demonstrated track record of execution and delivery excellence. Advent is the ideal partner for us, with deep expertise in healthcare, and a global network of professionals and experts. Their experience and resources will launch the next phase of growth for Suven pharma. This move will benefit Suven platform immensely. The proposed collaboration with Cohance is a win-win for Suven and its public shareholders. It will help us offer a broader set of services and multi sites to our customers” said Mr. Venkateswarlu Jasti, Managing Director at Suven Pharmaceuticals Ltd.

“We are extremely pleased with this win-win transaction. We believe that Suven is a world class CDMO with a credible track record and a great roster of clientele to its name. We plan
to build on Suven’s capabilities and make it one of the global leaders in the CDMO space. We intend to explore a merger of Cohance with Suven in a manner which is synergistic and accretive for Suven’s shareholders.” said Ms. Shweta Jalan, Managing Partner and Head of Advent International in India.

Suven Pharma, which was demerged from its parent entity, Suven Life Sciences, in 2020, is one of the leaders in the India pharma CDMO space with high growth (>20% CAGR over last 4 years) and profitability (>43% EBITDA margins). Suven does ~90% of its business with innovators and follows the customer from Phase 1 to commercialization. It has a strong pipeline of Phase 3 and late Phase 2 molecules with 100+ active projects.

“Our vision for Suven is to build a $1 billion global leader, by executing effectively on the product pipeline, building new marquee customers, turbo-charging business development, and scaling up manufacturing and R&D. We will also look at acquiring synergistic businesses globally, to further build capabilities and gain new customer access” said Mr. Pankaj Patwari, Managing Director at Advent International.

Cohance Lifesciences (www.cohance.com), wholly owned by Advent, was formed in November 2022 to create a new brand identity for its CDMO and API platform, with an intention of bringing together three Advent portfolio companies – RA Chem Pharma, ZCL Chemicals and Avra Laboratories. Cohance’s two business units, CDMO and API+, cater to development and manufacturing for pharma and specialty chemical innovators, and leading global generic companies with complex product requirements respectively. It has seven manufacturing facilities. Cohance recorded a total proforma revenue of ~INR 1,280 crores (FY 2021-22) and has grown at a market leading >21% CAGR organically in the last two years.

“The potential combination of Suven and Cohance has the ability to become a powerhouse operating across the pharmaceutical value chain. The combined entity will have three massive growth vectors across pharma CDMO, speciality chemicals and merchant API, each of which have strong macro tailwinds. There are strong front-end and operational synergies between the two businesses which will be leveraged” added Mr. Pankaj Patwari.

Advent has been investing in India since 2007 and founded its Mumbai office in 2009. Currently, it has invested/committed over $3.2 billion across 14 companies with headquarters or operations in India in sectors such as business and financial services, retail, consumer and leisure, healthcare, industrial and technology. Previous healthcare investments in India also include Bharat Serums and Vaccines. Globally, Advent has invested over US$ 10.4 billion across 51 companies in healthcare.

Advent was advised on this transaction by Kotak Investment Banking and Avendus Capital while Suven had Barclays Bank Plc as their exclusive financial advisor.

About Advent International

Founded in 1984, Advent International is one of the largest and most experienced global private equity investors. The firm has invested in over 400 private equity investments across 41 countries, and as of June 30, 2022, had $96 billion in assets under management. With 15 offices in 12 countries, Advent has established a globally integrated team of over 285 private equity investment professionals across North America, Europe, Latin America and Asia. The firm focuses on investments in five core sectors, including business and financial services; health care; industrial; retail, consumer and leisure; and technology. For over 35 years, Advent has been dedicated to international investing and remains committed to partnering with management teams to deliver sustained revenue and earnings growth for its portfolio companies.

For more information, visit

Website: www.adventinternational.com LinkedIn: www.linkedin.com/company/advent-international

Media contacts

Advent International

India:
Ketchum Sampark
Khushal Devera
Tel: +91 9819666376
khushal.devera@ketchumsampark.com

 

Tredence Raises $175 Mn in Series B Funding from Advent International

The funding from Advent International will help Tredence build on growth momentum, strengthen vertical capabilities, and reach a broader customer base

SAN JOSE | BOSTON | BANGALORE | MUMBAI – December 22, 2022Tredence, the Data Science and AI Solutions company, today announced it has raised USD 175 million in Series B funding from Advent International (“Advent”) to accelerate data-fueled growth and AI value realization for industries. Advent is one of the largest and most experienced global private equity investors. The full financial terms of the agreement have not been disclosed.

Advent will acquire a minority stake in Tredence with the $175 million investment. Advent has significant investment experience in the technology services and software sectors. Recent IT and information services investments include Encora, CI&T, NielsenIQ, Neoris, Sophos Solutions, Aareon, Canvia, and QuEST Global Services.

The existing investor Chicago Pacific Founders (“CPF”), a leading private equity firm, will continue to be a meaningful shareholder in Tredence. CPF made its initial investment in Tredence in December 2020.

Founded in 2013 by Shub Bhowmick, Sumit Mehra, and Shashank Dubey, Tredence aims to bridge the gap between insight delivery and value realization, providing customers with a differentiated approach to data and analytics through tailor-made solutions.

Advent, alongside Tredence’s co-founders and CPF, will work with the company through continued investment in vertical and domain expertise, IP and accelerator repository, channel partner development, and operational excellence. The partnership will help drive Tredence’s vision to become the world’s most indispensable data and analytics partner. As a part of the transaction, Advent will be joining the Tredence board.

“We are thrilled to welcome Advent as a partner to Tredence,” said Tredence CEO Shub Bhowmick. “Advent’s global reach, deep sector expertise, and vast experience in scaling businesses like ours through organic and inorganic growth will be invaluable to us as we look to drive continued business innovation. Tredence was founded to help clients solve some of the most complex challenges across industries through pragmatic innovation and continuous experimentation. CPF has been a value-added partner over the last few years, and we are excited to be joined by Advent on this journey.”

“Data analytics is an exciting segment within digital IT services with secular growth. The practice is fueled by the rise in data created and captured globally, the reduced cost of compute and storage, and the opportunity for enterprises to tap into valuable insights to drive competitive advantage,” said Shweta Jalan, Managing Partner at Advent International in India. “Tredence has built the business with deep domain expertise that positions it well to become a category-defining leader in the space. We are very excited to partner with Tredence in the next chapter of growth as they build a $500M revenue organization.”

“Tredence is leading the way in designing data analytics strategies, uncovering actionable insights, and implementing outcomes-based AI engagement models for clients,” said Mary Tolan, Founder & Managing Partner, Chicago Pacific Founders. “Through its portfolio of AI/ML solutions, the company has led the charge for world-class data transformation initiatives for enterprises across industries. We remain confident in Tredence’s ability to deliver long-term financial results for its shareholders.”

In 2021, the company devised a vertical AI go-to-market strategy that combines deep data science expertise with business context to solve daunting industry problems. The company’s vertical AI strategy will focus on ATOM.AI, an integrated accelerator ecosystem that guides enterprises from design to experience to value.

About Tredence Inc.

Tredence is a global data science solutions provider focused on solving the last mile problem in AI. The ‘last mile’ is the gap between insight creation and value realization. Headquartered in San Jose, the company embraces a vertical-first approach and an outcome-driven mindset to help clients win and accelerate value realization from their analytics investments. Tredence is 1,800-plus employees strong with offices in San Jose, Foster City, Chicago, London, Toronto, and Bangalore, with the largest companies in retail, CPG, hi-tech, telecom, healthcare, travel, and industrials as clients.

For more information, please visit www.tredence.com and follow us on LinkedIn.

About Advent International

Founded in 1984, Advent International is one of the largest and most experienced global private equity investors. The firm has invested in over 400 private equity investments across 41 countries, and as of September 30, 2022, had $89 billion in assets under management. With 14 offices in 12 countries, Advent has established a globally integrated team of over 285 private equity investment professionals across North America, Europe, Latin America and Asia. The firm focuses on investments in five core sectors, including business and financial services; health care; industrial; retail, consumer and leisure; and technology.

For more information, please visit www.adventinternational.com and follow Advent on LinkedIn.

About Chicago Pacific Founders

Based in Chicago and San Francisco, Chicago Pacific Founders (“CPF”) is a leading healthcare private equity firm focused on investing in growth companies within value-based care, healthcare services, AI and tech enabled services, and providing for aging populations. CPF’s leadership team is made up of former healthcare founders, entrepreneurs, and investment professionals with a passion and track record of building high quality businesses.

For more information, please visit http://www.cpfounders.com and follow CPF on LinkedIn

Media contacts

India
Sivaram K
Tredence Inc.
Tel: +91 99860 70780
Sivaram.k@tredence.com

US
Sophia Templin
FGS Global
US PR Contact for Advent
Tel: +1 646 805 2000
Adventinternational-US@fgsglobal.com

Joanne Hogue
Smart Connections PR
US PR Contact for Tredence
Tel: +1 860 941 7065
joanne@smartconnectionspr.com

Advent International launches Cohance Lifesciences, a new brand identity for its API platform

API platform to comprise of RA Chem Pharma, ZCL Chemicals and Avra Laboratories

The platform hopes to add more assets in the future and aims to be a top three merchant API and CDMO company in India

Mumbai, November 1, 2022: Advent International (“Advent”), one of the world’s largest and most experienced private equity investors, today announced the launch of Cohance Lifesciences, a new brand identity for its API and CDMO platform, which would comprise of three portfolio companies in RA Chem Pharma, ZCL Chemicals and Avra Laboratories.

The setting up of Cohance Lifesciences is significant, as it would help in establishing a unified new brand identity for the API and CDMO platform, to better reflect its vision and operating philosophy. The new brand brings its API-focused assets together under one platform. The platform is also forward integrated into pellets, formulations and clinical research to provide end-to-end offerings to its customers.

The company intends to add more assets in the future with the vision to become one of the top three merchant API and CDMO companies in India.

Speaking on the initiative, Pankaj Patwari, Managing Director, Advent, said, “We are very happy to announce the launch of our new platform, Cohance Lifesciences. Over the last two years, Advent International has acquired three unique, yet complementary businesses in the API/CDMO space and has built a meaningful market position, demonstrating strong growth.”

Elaborating on the initiative and how Advent operates its companies with a common operating philosophy and values, Mr. Patwari said, “We have built a single leadership team for this API platform, which will help us to drive strong growth, synergies and operational efficiencies. Our business model has a strong focus on customer service, sustainability, efficient infrastructure and robust quality systems.”

Dr. V Prasada Raju, MD and CEO, Cohance Lifesciences, said, “Our vision is to be amongst the top three merchant API and CDMO players in India. The name ‘Cohance’ is crafted by fusing ‘collaboration’, ‘co-creation’ and ‘enhancement’. At Cohance Lifesciences, the team possesses the spirit of co-creation and collaboration to relentlessly enhance value, as we build a best-in-class company to help our customers serve patients worldwide.”

Advent’s journey in the API space began with a controlling stake in RA Chem Pharma in October 2020, followed by controlling stakes in ZCL Chemicals in March 2021 and Avra Laboratories in April 2022. The platform, now wholly owned by Advent, has already built a solid track record of high profitability and strong growth.

Advent has been investing in India since 2007 and founded its Mumbai office in 2009. Currently, it has invested/committed over $3.4 billion across 14 companies with headquarters or operations in India in sectors such as business and financial services, retail, consumer and leisure, healthcare, industrial and technology. Previous healthcare investments in India also include Bharat Serums and Vaccines. Globally, Advent has invested over US$ 10.4 billion across 51 companies in healthcare.

Advent International

Founded in 1984, Advent International is one of the largest and most experienced global private equity investors. The firm has invested in over 400 private equity investments across 41 countries, and as of June 30, 2022, had $96 billion in assets under management. With 15 offices in 12 countries, Advent has established a globally integrated team of over 285 private equity investment professionals across North America, Europe, Latin America and Asia. The firm focuses on investments in five core sectors, including business and financial services; health care; industrial; retail, consumer, and leisure; and technology. For over 35 years, Advent has been dedicated to international investing and remains committed to partnering with management teams to deliver sustained revenue and earnings growth for its portfolio companies.

For more information, visit
Website: www.adventinternational.com
LinkedIn: www.linkedin.com/company/advent-international

Cohance Lifesciences

Cohance Lifesciences is a global, merchant API & CDMO platform. With over 1,900 employees, 8 manufacturing units (including 5 USFDA approved units) and 3 dedicated R&D units, across 3 companies, Cohance serves its marquee clients as a partner of choice in a range of niche Intermediates, APIs, Pre-Formulation Intermediates, Formulations & Specialty Chemicals across both Innovator and Generic molecules. As a global player, the company serves customers across ~58 countries and has a growing product basket of 80+ molecules backed by robust R&D, regulatory capabilities and manufacturing infrastructure.

Media contacts

Advent International
India:
Ketchum Sampark
Khushal Devera
Tel: +91 9819666376
khushal.devera@ketchumsampark.com

Advent International Appoints Heather Kennedy Miner as Managing Director

Former Goldman Sachs Partner to Assume Role of Chief Operating Officer on January 1

BOSTON, November 1, 2022 – Advent International (“Advent”), one of the largest and most experienced global private equity investors, today announced the appointment of Heather Kennedy Miner as Managing Director. Ms. Miner will assume the role of Chief Operating Officer effective January 1, 2023, with responsibility for driving Advent’s operations globally, including executing the firm’s strategic growth initiatives, overseeing marketing and communications, and delivering on talent development priorities.

Ms. Miner joins Advent from Goldman Sachs (NYSE: GS), where she held a number of leadership positions during her nearly two-decade tenure. Most recently, she served as Partner and Chief Operating Officer as well as Global Co-Head of Client Solutions and Capital Markets for Goldman Sachs’ $2.4 trillion Asset Management business. She also previously served as Goldman Sachs’ Global Head of Investor Relations. Ms. Miner began her career in the Financial Institutions Group at UBS.

“We are delighted to welcome Heather to Advent’s leadership team,” said David Mussafer, Managing Partner and Co-Chair of Advent’s Executive Committee. “Heather brings a diversified skillset and partnership ethos that we believe will allow her to add significant value to our investment and operating teams. With her impressive background and deep expertise, Heather is well suited to help us advance our key strategic and financial goals.”

“I’m thrilled to be joining the dynamic and talented team at Advent during an incredibly exciting time for the firm,” said Ms. Miner. “With $25 billion in new capital to deploy in our latest flagship fund, GPE X, Advent is at an auspicious juncture. I look forward to engaging with our team and partners across the globe and contributing to the firm’s continued success.”

“During her twenty-plus year career, and throughout multiple market cycles, Heather has led functions which are critical to scale a global investment management business,” said James Brocklebank, Managing Partner and Co-Chair of Advent’s Executive Committee. “As we embark on Advent’s exciting next stage of growth, we are incredibly pleased to continue expanding and diversifying our senior team as we further build out our platform and continue to enhance our operating performance.”

Ms. Miner earned a B.S. in Finance from the Carroll School of Management at Boston College and an MBA from the Stern School of Business at New York University.

Advent International

Founded in 1984, Advent International is one of the largest and most experienced global private equity investors. The firm has invested in over 395 private equity investments across 41 countries, and as of June 30, 2022, had $96 billion in assets under management. With 15 offices in 12 countries, Advent has established a globally integrated team of 270 private equity investment professionals across North America, Europe, Latin America and Asia. The firm focuses on investments in five core sectors, including business and financial services; health care; industrial; retail, consumer and leisure; and technology. For over 35 years, Advent has been dedicated to international investing and remains committed to partnering with management teams to deliver sustained revenue and earnings growth for its portfolio companies.

For more information, visit
Website: www.adventinternational.com
LinkedIn: www.linkedin.com/company/advent-international

Media contacts

US
Kerry Golds or Sophia Templin
FGS Global
Tel: +1 646 805 2000
Adventinternational-US@fgsglobal.com

UK
Graeme Wilson or Harry Cameron
Tulchan Group
Tel: +44 20 7353 4200
Advent@tulchangroup.com

Advent International appoints Shar Dubey and Mandy Ginsberg as Operating Partners

Former Match Group executives bring 54 years of collective experience to further strengthen Advent’s consumer technology practice

BOSTON, October 20, 2022 – Advent International (“Advent”), one of the largest and most experienced global private equity investors, today announced the appointments of Shar Dubey and Mandy Ginsberg as Operating Partners. Dubey and Ginsberg will play key roles in further building out Advent’s consumer technology practice and work collaboratively with the firm’s consumer and technology investment teams and the management teams of its portfolio companies.

Dubey and Ginsberg bring substantial experience in building digital communities and scaling disruptive global businesses, having each previously served as Chief Executive Officer of Match Group (NASDAQ: MTCH), a leading provider of digital technologies designed to help people make meaningful connections. Dubey and Ginsberg were instrumental in developing the online dating category, growing the business and leading the preparation and spin off of Match Group from international consumer internet conglomerate InterActiveCorp (“IAC”) in 2020. Ginsberg served as CEO from 2018-2020 before transitioning the role to Dubey, who held the position until May 2022. During the combined four plus years under their leaderships, Dubey and Ginsberg helped grow Match Group’s revenue and adjusted operating income by approximately 125%, respectively.

“We’re thrilled to welcome Shar and Mandy as advisors to Advent as we continue to bolster the breadth and depth of our Operating Partners, who play a critical role in the evolution and growth of our portfolio companies around the world,” said Tricia Glynn, Managing Director on Advent’s consumer team. “Both executives have an innate understanding of how to build market leaders and digital communities, and as technology becomes a greater part of our lives, community is now more important than ever. Moreover, consumer technology is a high-growth sector that we have closely followed for a number of years and one which we believe is a strategic fit for our investment strategy and operating model, especially with the guidance and partnership of Shar and Mandy.”

“I’m excited to work with Advent alongside one my closest personal and professional friends in Mandy,” said Dubey. “As one of the largest and most recognized alternative investors, I have been impressed with the well-thought-out strategy and executed steps Advent has taken to scale some of the world’s most prominent companies across the retail, consumer, leisure and technology spaces. I am eager to begin working closely with portfolio companies to help strategize, identify and implement meaningful growth opportunities.”

“The consumer technology industry is a highly attractive and evolving sector that offers innovative products, services and experiences that can meaningfully improve and impact lives in a variety of categories from health and relationships to travel and entertainment,” said Ginsberg. “After working hand in hand with Shar for many years, it’s a pleasure to have the opportunity to partner with her again in a new venture and to provide our collective insights to dynamic digital businesses. Advent is a powerful and exciting platform where we can bring our industry knowledge, operational expertise and leadership experience to help create even further value at the firm’s portfolio companies.”

“Both Shar and Mandy maintain impeccable track records and, more importantly, are highly respected professionals who we believe will provide significant value add to our portfolio companies and their management teams while also serving as key advisors to our investment staff,” said Bryan Taylor, Managing Partner and head of Advent’s technology team. “We welcome them and look forward to their future contributions to the firm and our growing portfolio of leading consumer technology companies.”

Prior to serving as CEO of Match Group, Dubey held a number of roles within IAC and its brands, including President of Match Group, Chief Operating Officer of Tinder, President of Americas at Match Group, Chief Product Officer of the Princeton Review and Tutor.com and Chief Product Officer at Match.com and Chemistry.com. Before joining Match Group and IAC, Dubey served as a Director of Product Marketing and Management at i2 Technologies (NKA: Blue Yonder Group) and as an engineer at Texas Instruments. Dubey currently serves on the Board of Directors at Naspers Limited (JSE: NPN), Prosus N.V. (JSE: PRX), Fortive Corporation (NYSE: FTV), Match Group and MyFitnessPal. In 2021, she was named one of Fortune’s “Most Powerful Women in Business” and was the recipient of Tech Leader of the Year for Vogue’s “Women of The Year” awards. Dubey earned a MS in Engineering from The Ohio State University and a BS in Engineering from the Indian Institute of Technology.

Before leading Match Group as global and North America CEO, respectively, Ginsberg served in numerous roles at IAC over 14 years, including CEO of the Princeton Review and Tutor.com and President of Match.com. Ginsberg previously served as a Vice President of Marketing at i2 Technologies and advised consumer technology clients as a Vice President at public relations firm, Edelman. She began her career in marketing in the high-tech sector in Tel Aviv, Israel. Ginsberg currently serves on the Board of Directors at Uber Technologies (NYSE: UBER) and ThredUp (NASDAQ: TDUP). She previously served as a director at Match Group, J.C. Penney Company and Care.com. Ginsberg earned an MBA from The Wharton School of the University of Pennsylvania and a BA in English and Spanish Literature from the University of California, Berkeley.

ABOUT ADVENT INTERNATIONAL

Founded in 1984, Advent International is one of the largest and most experienced global private equity investors. The firm has invested in over 400 private equity investments across 41 countries, and as of June 30, 2022, had $96 billion in assets under management. With 15 offices in 12 countries, Advent has established a globally integrated team of 285 private equity investment professionals across North America, Europe, Latin America and Asia. The firm focuses on investments in five core sectors, including business and financial services; health care; industrial; retail, consumer and leisure; and technology. For over 35 years, Advent has been dedicated to international investing and remains committed to partnering with management teams to deliver sustained revenue and earnings growth for its portfolio companies.

For more information, visit
Website: www.adventinternational.com
LinkedIn: www.linkedin.com/company/advent-international

Media contacts

US
Kerry Golds or Sophia Templin
FGS Global
Tel: +1 212 687 8080
Adventinternational-US@fgsglobal.com

UK
Graeme Wilson or Harry Cameron
Tulchan Group
Tel: +44 20 7353 4200
Advent@tulchangroup.com

© 2002-2024 Advent International, L.P. All rights reserved

LinkedIn Instagram youtube